Detection of mutant p53 in hepatocellular cancer from Turkey and its correlation with clinicopathologic parameters.

doi:10.1023/a:1023031008757

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Detection of mutant p53 in hepatocellular cancer from Turkey and its correlation with clinicopathologic parameters.

Digestive diseases and sciences - 1 May 2003

Cengiz Cem, Akarca Ulus S, Goker Erdem, Yuce Gul

Abstract excerpt

The samples of hepatocellular carcinoma from Turkey, a country with a high prevalence of hepatitis B virus and hepatitis C virus, but low dietary exposure to aflatoxin B1, were examined in order to detect the frequency of mutant p53 and its association with clinical and pathological data. Fifty-two samples of hepatocellular cancer from the patients who were diagnosed in our clinic were included in this study. The...

Topics

Adolescent
Adult
Aged
Biopsy, Needle
Carcinoma, Hepatocellular
Culture Techniques
Enzyme-Linked Immunosorbent Assay
Female
Genetic Predisposition to Disease
Hepatitis B
Hepatitis C, Chronic
Humans
Incidence
Liver Neoplasms

Source

Open in PubMed

Identifiers

PMID: 12772781
DOI: 10.1023/a:1023031008757

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Male

Middle Aged

Mutation

Probability